Literature DB >> 8939940

A discrete site modulates activation of I domains. Application to integrin alphaMbeta2.

L Zhang1, E F Plow.   

Abstract

A central characteristic of integrin adhesion receptors is their capacity to become activated, thereby enhancing their affinity for ligands. Here, we report the identification of a discrete site within the I domain of integrin alphaMbeta2, which modulates the adhesive activity of this receptor. Based upon the crystal structure, this region is composed of two short and spatially proximal loops, E162QLKKSKTL and Q190NNPNPRS. Mutations in these loops yield receptors which support spontaneous cell adhesion to fibrinogen, whereas mutation of an adjacent region and wild-type receptors require activation to adhere to this substrate. An activating monoclonal antibody enhanced the adhesive activity of one but not the other loop mutants, suggesting that the activation states of these two mutant receptors were not identical. Given that similar I domains exist in several other integrin alpha subunits and non-integrin proteins, and possibly in all integrin beta subunits, these two loop segments may represent a universal target for controlling integrin activation and the function of other I domain-containing proteins. In support of this hypothesis, several naturally occurring mutations that activate von Willebrand factor map to the same loops of its I(A) domain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939940     DOI: 10.1074/jbc.271.47.29953

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Engineered allosteric mutants of the integrin alphaMbeta2 I domain: structural and functional studies.

Authors:  Clare J McCleverty; Robert C Liddington
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

2.  Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring.

Authors:  Wei Yang; Motomu Shimaoka; Azucena Salas; Junichi Takagi; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

3.  Conformational changes in tertiary structure near the ligand binding site of an integrin I domain.

Authors:  C Oxvig; C Lu; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus.

Authors:  B Schnyder; P C Meunier; B D Car
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

Review 5.  Cell adhesion in vascular biology. New insights into integrin-ligand interaction.

Authors:  J C Loftus; R C Liddington
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

6.  Molecular basis for the interaction of low density lipoprotein receptor-related protein 1 (LRP1) with integrin alphaMbeta2: identification of binding sites within alphaMbeta2 for LRP1.

Authors:  Sripriya Ranganathan; Chunzhang Cao; Jason Catania; Molly Migliorini; Li Zhang; Dudley K Strickland
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

7.  NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.

Authors:  J R Huth; E T Olejniczak; R Mendoza; H Liang; E A Harris; M L Lupher; A E Wilson; S W Fesik; D E Staunton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

8.  Neisseria gonorrhoeae pilin glycan contributes to CR3 activation during challenge of primary cervical epithelial cells.

Authors:  Michael P Jennings; Freda E-C Jen; Louise F Roddam; Michael A Apicella; Jennifer L Edwards
Journal:  Cell Microbiol       Date:  2011-03-04       Impact factor: 3.715

9.  Integrin αXβ₂ is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections.

Authors:  Samir Jawhara; Elzbieta Pluskota; Dmitriy Verbovetskiy; Olena Skomorovska-Prokvolit; Edward F Plow; Dmitry A Soloviev
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.